Month: January 2022

Researchers from the Veteran’s Health Administration, Academia, and Adaptive Testing Technologies Validate the Computerized Adaptive Test Suicide Scale (CAT-SS) for U.S. Military Veterans

CHICAGO, Jan. 25, 2022 /PRNewswire/ -- A promising new research study published today in the Public Library of Science (PLOS) ONE demonstrates...

Atomwise Strengthens its Management Team, Adds Veteran Biopharma Leader David Thomson, Ph.D. as Chief Scientific Officer and Two Additional Senior Appointments

SAN FRANCISCO, Jan. 25, 2022 /PRNewswire/ -- Atomwise, a leader in using artificial intelligence (AI) for small molecule drug discovery, announced...

Moderna Announces First Participant Dosed in Phase 2 Study of Omicron-Specific Booster Candidate and Publication of Data on Booster Durability Against Omicron Variant

Phase 2 study of Omicron-specific booster candidate (mRNA-1273.529) will include two cohorts: one including participants who received the two-dose primary...

error: Content is protected !!